| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.0M | -6.7% | -32.5% |
| Cost of Revenue | $2.0M | -17.2% | -43.8% |
| Gross Profit | $3.0M | +1.7% | -22.2% |
| R&D Expense | $3.3M | -10.6% | -38.9% |
| SG&A Expense | $4.6M | +42.2% | +22.5% |
| Operating Income | -$9.5M | -3.1% | +21.2% |
| Interest Expense | $1.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $31.9M | +45.3% | +105.2% |
| Accounts Receivable | $2.4M | -7.1% | -52.0% |
| Inventory | $4.9M | +5.6% | +2.7% |
| Current Assets | $42.2M | +31.1% | +42.9% |
| Total Assets | $117.7M | +8.7% | +7.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$20.1M | — | — |
| Capital Expenditures | $116K | — | — |
| Investing Cash Flow | -$116K | — | — |
| Financing Cash Flow | $24.3M | — | — |
| Free Cash Flow | -$20.2M | — | — |
| — |
| — |
| Pre-tax Income | -$10.5M | +19.4% | +15.2% |
| Income Tax | $0 | — | +100.0% |
| Net Income | -$10.5M | +19.4% | +15.1% |
| EPS (Basic) | $2.96 | +1544.4% | +1084.0% |
| EPS (Diluted) | $2.96 | +1544.4% | +1084.0% |
| $9.3M |
| -4.9% |
| -50.8% |
| Long-term Debt | $30.6M | +0.4% | +51.7% |
| Stockholders' Equity | $74.9M | +17.1% | +28.1% |